Literature DB >> 17212349

Primary lateral sclerosis.

Mike A Singer1, Jeffrey M Statland, Gil I Wolfe, Richard J Barohn.   

Abstract

The spectrum of motor neuron diseases ranges from disorders that clinically are limited to lower motor neurons to those that exclusively affect upper motor neurons. Primary lateral sclerosis (PLS) is the designation for the syndrome of progressive upper motor neuron dysfunction when no other etiology is identified. Distinction between PLS and the more common amyotrophic lateral sclerosis (ALS) relies primarily on recognition of their symptoms and signs, as well as on ancillary, although non-specific, laboratory data. In this review, we survey the history of PLS from the initial descriptions to the present. We discuss the role of laboratory, electrodiagnostic, and imaging studies in excluding other diagnoses; the findings from major case series of PLS patients; and proposed diagnostic criteria. Consistent differences are evident in patients classified as PLS compared to those with ALS, indicating that, despite its limitations, this clinical designation retains important utility.

Entities:  

Mesh:

Year:  2007        PMID: 17212349     DOI: 10.1002/mus.20728

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  37 in total

1.  Neuroimaging of motor neuron diseases.

Authors:  Jan Kassubek; Albert C Ludolph; Hans-Peter Müller
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

2.  [Slowly progressive dysarthria in primary lateral sclerosis].

Authors:  P P Urban; I Wellach; C Pohlmann
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

3.  Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging.

Authors:  Alexander Unrath; Hans-Peter Müller; Axel Riecker; Albert C Ludolph; Anne-Dorte Sperfeld; Jan Kassubek
Journal:  Hum Brain Mapp       Date:  2010-11       Impact factor: 5.038

4.  Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.

Authors:  Andrew D Schweitzer; Tian Liu; Ajay Gupta; Karen Zheng; Stephen Seedial; Alexander Shtilbans; Mona Shahbazi; Dale Lange; Yi Wang; A John Tsiouris
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

Review 5.  Primary Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; Mazen M Dimachkie; Mary Kay Floeter; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

6.  Voxel-based diffusion tensor imaging detects pyramidal tract degeneration in primary lateral sclerosis.

Authors:  L C Tzarouchi; A P Kyritsis; S Giannopoulos; L G Astrakas; M Diakou; M I Argyropoulou
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

7.  White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis.

Authors:  Nobue K Iwata; Justin Y Kwan; Laura E Danielian; John A Butman; Fernanda Tovar-Moll; Elham Bayat; Mary Kay Floeter
Journal:  Brain       Date:  2011-07-28       Impact factor: 13.501

8.  Disease spread through contiguity and axonal tracts in primary lateral sclerosis.

Authors:  Lauren Flynn; Matthew Stephen; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2014-01-27       Impact factor: 3.217

9.  Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Authors:  John Ravits; Stanley Appel; Robert H Baloh; Richard Barohn; Benjamin Rix Brooks; Lauren Elman; Mary Kay Floeter; Christopher Henderson; Catherine Lomen-Hoerth; Jeffrey D Macklis; Leo McCluskey; Hiroshi Mitsumoto; Serge Przedborski; Jeffrey Rothstein; John Q Trojanowski; Leonard H van den Berg; Steven Ringel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 10.  Molecular logic of neocortical projection neuron specification, development and diversity.

Authors:  L C Greig; M B Woodworth; M J Galazo; H Padmanabhan; J D Macklis
Journal:  Nat Rev Neurosci       Date:  2013-10-09       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.